| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one;hydrochloride |
N-ACETYL-, COMPD. WITH (3S,5S,6R)-3-AMINO-6-METHYL-1-(2,2,2-TRIFLUOROETHYL)-5-(2,3,6-TRIFLUOROPHENYL |
1375471-14-9 |
詳細(xì)
|
| 5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide |
GSK2982772 |
1622848-92-3 |
詳細(xì)
|
| SAR-260093 |
5-乙基-2-[4-[4-[[[4-(1H-四氮唑-1-基)苯基]氧基]甲基]噻唑-2-基]哌啶-1-基]嘧啶 |
1037792-44-1 |
詳細(xì)
|
| 2-[3-[4-[(6-amino-3-pyridyl)amino]-6-ethoxy-quinazolin-2-yl]phenoxy]-N-isopropyl-acetamide |
|
2406304-03-6 |
詳細(xì)
|
| PF-06840003 |
3-(5-氟-1H-吲哚-3-基)-2,5-吡咯烷二酮 |
198474-05-4 |
詳細(xì)
|
| Sarolaner |
沙羅拉納 |
1398609-39-6 |
詳細(xì)
|
| 1-(6-amino-3,5-difluoro-2-pyridyl)-7-[[3-[1-[1-(6-amino-3,5-difluoro-2-pyridyl)-3-carboxy-8-chloro-6-fluoro-4-oxo-7-quinolyl]azetidin-3-yl]oxy-2-hydroxy-propyl]amino]-8-chloro-6-fluoro-4-oxo-quinoline-3-carboxylic acid |
德拉沙星二聚體雜質(zhì) |
1093185-35-3 |
詳細(xì)
|
| (-)-Tetrabenazine |
(3S,11BS)-1,3,4,6,7,11B-六氫-9,10-二甲氧基-3-(2-甲基丙基)-2H-苯并[A]喹嗪-2-酮 |
1026016-84-1 |
詳細(xì)
|
| PF-06873600 |
PF-06873600 |
2185857-97-8 |
詳細(xì)
|
| MTS |
1-甲氧基-1-(三甲基甲硅氧基)-2-甲基-1-丙烯 |
31469-15-5 |
詳細(xì)
|
| 4-[(2R,4R)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidyl]benzoic acid |
|
1644670-39-2 |
詳細(xì)
|
| 5-amino-1-[(4-bromo-2-fluoro-phenyl)methyl]-N-(2,5-dimethoxyphenyl)triazole-4-carboxamide |
|
866347-75-3 |
詳細(xì)
|
| N-{3-[(2-{[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide |
艾維替尼 |
1557267-42-1 |
詳細(xì)
|
| tert-butyl N-[(3R,5R,6R)-6-methyl-2-oxo-5-phenyl-3-piperidyl]carbamate |
|
1426935-98-9 |
詳細(xì)
|
| N-[(3R)-3-(2-chloro-5-fluoro-phenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxo-isoindolin-4-yl]-3-fluoro-5-(trifluoromethyl)benzamide |
(R)-N-(3-(2-氯-5-氟苯基)-6-(5-氰基-[1,2,4]三唑并[1,5-A]吡啶-6-基)-1-氧代異吲哚啉-4-基)-3-氟-5-(三氟甲基)苯甲酰胺 |
2733573-94-7 |
詳細(xì)
|
| 6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide |
BMS-986165 |
1609392-27-9 |
詳細(xì)
|
| 1-(2,2-difluoro-1,3-benzodioxol-4-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethyl-ethyl)indol-5-yl]cyclopropanecarboxamide |
(R)-1-(2,2-二氟苯并[D][1,3]二氧戊環(huán)-4-基)-N-(1-(2,3-二羥丙基)-6-氟-2-(1-羥基) -2-甲基丙-2-基)-1H-吲哚-5-基)環(huán)丙烷-1-甲酰胺 |
1419101-35-1 |
詳細(xì)
|
| NSC 332548 |
2-甲基-beta-萘并噻唑 |
2682-45-3 |
詳細(xì)
|
| Aripiprazole lauroxil |
月桂酰阿立派唑 |
1259305-29-7 |
詳細(xì)
|
| Suzetrigine |
SUZETRIGINE |
2649467-58-1 |
詳細(xì)
|
| OWL 833 |
GLP-1 receptor agonist 1 |
2212020-52-3 |
詳細(xì)
|
| tert-butyl N-[(3R,5R,6S)-6-methyl-2-oxo-5-phenyl-3-piperidyl]carbamate |
CARBAMIC ACID, N-[(3S,5S,6R)-6-METHYL-2-OXO-5-PHENYL-3-PIPERIDINYL]-, 1,1-DIMETHYLETHYL ESTER |
1375541-78-8 |
詳細(xì)
|
| GW-9508 |
885101-89-3(GW9508) |
885101-89-3 |
詳細(xì)
|
| TCMDC 123865 |
特拉唑嗪雜質(zhì)E |
102839-00-9 |
詳細(xì)
|
| (6R)-1'-tert-butyl-3-chloro-spiro[5,7-dihydrocyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-2'-one |
|
1456803-73-8 |
詳細(xì)
|
| (6S)-3-bromo-1'-tert-butyl-spiro[5,7-dihydrocyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-2'-one |
|
1455358-63-0 |
詳細(xì)
|
| CYR-101 |
MIN-101 |
359625-79-9 |
詳細(xì)
|
| 1-(3-carboxylatopropyl)-11-ethyl-1,2,3,4,8,9,10,11-octahydro-13λ-oxa-1,6,11-triazapentacen-13-ylium |
MR 121, Technical Grade |
185213-55-2 |
詳細(xì)
|
| Tolvaptan |
托伐普坦 |
150683-30-0 |
詳細(xì)
|
| Iloperidone |
伊潘立酮 |
133454-47-4 |
詳細(xì)
|
| 2-[(2,4-dichloro-3-pyridyl)methylsulfanyl]-4-methyl-1H-pyrimidin-6-one |
|
1256558-00-5 |
詳細(xì)
|
| PTPN2/1-IN-2 |
|
2407611-02-1 |
詳細(xì)
|
| (S,S)-Hydrobenzoin |
(S,S)-(-)-氫化苯偶姻 |
2325-10-2 |
詳細(xì)
|
| Fasiglifam |
TAK-875 |
1000413-72-8 |
詳細(xì)
|
| (1R)-3-(3,4-dimethoxyphenyl)-1-{3-[({2-[(2-{3-[(1R)-3-(3,4-dimethoxyphenyl)-1-{1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyloxy}propyl]phenoxy}acetamido)methyl]-3-(dimethylamino)propyl}carbamoyl)methoxy]phenyl}propyl (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate |
AP 20187 |
195514-80-8 |
詳細(xì)
|
| NSC 60534 |
1,4-二氧六環(huán)-2-酮 |
3041-16-5 |
詳細(xì)
|
| N-[4-[(2S,3R)-3-methoxy-1-phenyl-pyrrolidin-2-yl]thiazol-2-yl]-1-(4-pyridylmethyl)pyrrole-2-carboxamide |
|
2484865-70-3 |
詳細(xì)
|
| 7-(3-acetoxy-azetidin-1-yl)-1-(6-amino-3,5-difluoro-pyridin-2-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid ethyl ester |
|
1788054-85-2 |
詳細(xì)
|
| Sunitinib malate |
蘋果酸舒尼替尼 |
341031-54-7 |
詳細(xì)
|
| 1-[4-({[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino}methyl)piperidin-1-yl]prop-2-en-1-one |
埃沃布魯替尼 |
1415823-73-2 |
詳細(xì)
|
| PF-06651600 |
利特昔替尼 |
1792180-81-4 |
詳細(xì)
|
| Moxidectin |
莫西菌素 |
113507-06-5 |
詳細(xì)
|
| N-[(3R,4R)-3-[[6-(2,6-dichloro-3,5-dimethoxy-phenyl)quinazolin-2-yl]amino]tetrahydropyran-4-yl]prop-2-enamide |
N-[(3R,4R)-3-{[6-(2,6-二氯-3,5-二甲氧苯基)喹唑啉-2-基]氨基}噁烷-4-基]丙-2-烯酰胺 |
1707289-24-4 |
詳細(xì)
|
| Tilpisertib |
TILPISERTIB |
2065153-41-3 |
詳細(xì)
|
| N-tert-butyl-2-[3-[4-[(3,5-dimethyl-1H-pyrazol-4-yl)amino]-6-ethoxy-quinazolin-2-yl]phenoxy]acetamide |
|
2406304-47-8 |
詳細(xì)
|
| 1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one |
FGFR抑制劑(FGFR-IN-1) |
1448169-71-8 |
詳細(xì)
|
| RAS-IN-2 |
RAS-IN-2 |
2765081-21-6 |
詳細(xì)
|
| N-[(2-methyl-4-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}phenyl)methyl]-3-(propan-2-yloxy)azetidine-1-carboxamide |
BIIB068 |
1798787-27-5 |
詳細(xì)
|
| Dimethylacetamide (DMA) Ph. Eur. |
N,N-二甲基乙酰胺 |
127-19-5 |
詳細(xì)
|
| Tolebrutinib |
(R)-1-(1-丙烯酰哌啶-3-基)-4-氨基-3-(4-苯氧基苯基)-1H-咪唑并[4,5-C]吡啶-2(3H)-酮 |
1971920-73-6 |
詳細(xì)
|
| Tetrabenazine |
丁苯那嗪 |
58-46-8 |
詳細(xì)
|
| Lixivaptan |
利伐普坦 |
168079-32-1 |
詳細(xì)
|
| (3R)-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxylic acid |
|
2568065-21-2 |
詳細(xì)
|
| (αR)-α-[[(5R)-5-[3-Chloro-2-methyl-4-[2-(4-methyl-1-piperazinyl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy]-2-[[2-(2-methoxyphenyl)-4-pyrimidinyl]methoxy]benzenepropanoic acid |
(R)-MIK665 |
1799831-02-9 |
詳細(xì)
|
| 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide |
化合物INAXAPLIN |
2446816-88-0 |
詳細(xì)
|
| BMS-986205 |
（2R）-N-（4-氯苯基）-2 - [（1S，4S）-4-（6-氟喹啉-4-基）環(huán)己基]丙酰胺 |
1923833-60-6 |
詳細(xì)
|
| BTMABr3 |
芐基三甲基三溴化銨 |
111865-47-5 |
詳細(xì)
|
| 5-[[(4R)-3,3-difluoro-1-methyl-4-piperidyl]oxy]-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine |
化合物 ZN-A-1041 |
2414056-31-6 |
詳細(xì)
|
| Zongertinib |
宗格替尼 |
2728667-27-2 |
詳細(xì)
|
| 4-chloro-N-[(1,5-dimethyl-1H-pyrrol-2-yl)methyl]-3-sulfamoylbenzamide |
4-氯-N-((1,5-二甲基-1H-吡咯-2-基)甲基)-3-氨磺酰苯甲酰胺 |
793731-95-0 |
詳細(xì)
|
| Luxdegalutamide |
ARV-766 |
2750830-09-0 |
詳細(xì)
|
| Remibrutinib |
LOU-064 |
1787294-07-8 |
詳細(xì)
|
| N-[(furan-2-yl)methyl]-8-(4-methanesulfonylphenyl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine |
EED226 |
2083627-02-3 |
詳細(xì)
|
| Palbociclib hydrochloride |
帕布昔利布鹽酸鹽 |
827022-32-2 |
詳細(xì)
|
| 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione |
SB216763 |
280744-09-4 |
詳細(xì)
|
| tert-butyl N-[(3S,5S,6S)-6-methyl-2-oxo-5-phenyl-3-piperidyl]carbamate |
|
1426936-04-0 |
詳細(xì)
|
| benzamide, 4-(6-methoxy-3-pyridinyl)-n-[2-methyl-3-[[6-oxo-4-(1-piperazinyl)-1(6h)-pyridazinyl]methyl]phenyl]- |
4-(6-甲氧基吡啶-3-基)-N-(2-甲基-3-((6-氧代-4-(哌嗪-1-基)噠嗪-1(6H)-基)甲基)苯基)苯甲酰胺 |
1103458-91-8 |
詳細(xì)
|
| (2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.02,.0,1.012,1]nonadeca-1(18),8,12(17),13,15-pentaen-11-one |
帕米帕利 |
1446261-44-4 |
詳細(xì)
|